An Open -Label, Single-treatment , single period, single dose, clinical phase 1 study to asess the safety and tolerability of hepatitis B vaccine(r-DNA)I. P of M/s Cadila Healthcare Ltd, India in healthy , adult, male, human subjects.
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 02 Sep 2016 New trial record